Trajan Group Holdings (ASX:TRJ) disclosed its FY2026 financial results and FY27 first-quarter update at the Bell Potter Healthcare Conference on 17 November 2026, with CEO and Managing Director Stephen Tomisich and Interim CFO Simon Billingham presenting a group revenue of $161.4 million, down 3.1% from the prior corresponding period of $166.5 million.
Key Points
- FY2026 group revenue was $161.4M, compared to $166.5M in the prior corresponding period, down 3.1%
- Group nEBITDA declined to $13.2M from $15.5M in the prior corresponding period, down 14.7%
- Operating NPATA grew to $2.2M from $0.8M in the prior corresponding period, up 191.3%
- FY27 Q1 unaudited management accounts show rolling 12-month nEBITDA of $16.2M and net revenue up 3.8% versus FY26 Q1 on fixed forex rates
- Net debt increased to $34.6M from $29.5M in the prior corresponding period, up 17.0%
FY2026 Financial Results Detail
Trajan's FY2026 proforma gross margin was 38.9%, down 0.8 percentage points from the prior corresponding period of 39.8%. The company disclosed that H2 FY26 nEBITDA increased to $8.1M, up 61.8% from H1 FY26's $5.0M. On a fixed currency basis with AUD adjusted to H1 forex rates, group H2 nEBITDA rose to $10.5M. The company stated that approximately 85% of Trajan revenues are derived in USD and EUR, and that AUD appreciation in H2 FY26 impacted underlying H2 revenue by approximately $5.0M. Cash at period end was $12.6M, compared to $11.9M in the prior corresponding period, up 6.5%.
FY27 First-Quarter Unaudited Update
According to unaudited management accounts, Trajan's FY27 Q1 nEBITDA was approximately $3.5M, bringing the rolling 12-month nEBITDA to $16.2M. Net revenue, measured at fixed forex rates, rose 3.8% compared to FY26 Q1. The Components and Consumables segment recorded net revenue growth of 5.2%, while Disruptive Technologies grew 12.7%. Capital Equipment net revenue was down 1.2%. Net debt reduced by $1.6M during Q1. The company also disclosed that FY27 Q1 proforma gross margin percentage exceeded 42%, up 15% on Q1 prior year, with employee expense and scrap each down more than 8% on Q1 prior year.
Business Segments and Project Neptune Operational Update
Trajan described itself as a global developer and manufacturer of analytical and life science products with an organisation of approximately 600 people across ten manufacturing and operations sites in the US, Australia, Europe and Asia. The company's three operating segments are Components and Consumables, representing approximately 70% of revenue; Capital Equipment, approximately 30% of revenue; and Disruptive Technologies, less than 1% of revenue. The company stated that Project Neptune continues to drive efficiencies, with the business becoming leaner as the initiative gains traction, referencing a Trajan Sharewise Webinar held on 8 October 2026 as the source for operational improvement data.



Please wait processing your request...